AGT gene mutation
By Russell Browne (Dip. Adv. Nut.) · Specialist in Genetic Nutrition & Methylation Protocols
“AGT gene mutation” is the phrase most people search for, but the AGT changes discussed here are common polymorphisms (variants), not rare defects. This page explains what the AGT gene does, what the research genuinely supports around blood pressure, and what we observe in clinical practice — without overstating the case.
What is a AGT gene mutation?
A AGT “mutation” — more accurately a common gene polymorphism or variant — is a widespread variation that can influence how this gene and its enzyme work. These are common variants that shift relative likelihoods, not switches that determine your health.
What the AGT gene does
AGT provides instructions for making angiotensinogen, the starting molecule of the renin-angiotensin system — the hormone pathway that helps regulate blood pressure and fluid balance. Angiotensinogen is converted, in steps, into angiotensin II, which raises blood pressure. Because AGT sits at the start of this pathway, its variants have been of interest in blood-pressure research.
New to all this? Start with the overview
Bad Genes – The Genetic Advantage by Russell Browne is a plain-English tour of the common gene variants that most influence health — the ideal companion to your variant report, and a great place to see how the individual genes fit together.
AGT and blood pressure
Common AGT variants (for example M235T) have been studied for whether they are associated with differences in angiotensinogen levels and blood pressure. The relationship is influenced by salt intake, weight, other genes, and lifestyle — so AGT is one small piece of a much larger picture, not a switch that sets your blood pressure.
AGT Variants: What the Research Shows, and What We See in Practice
There is a lot written about these genes online, and much of it overstates the case. We separate two kinds of information: what the published research has found, and — kept distinct from it — the patterns we have observed in clinical practice.
What the research shows
AGT variants have been studied for associations with blood pressure and hypertension risk across various populations, with effects that are generally modest and inconsistent between studies.
Three things are essential to keep in view about this research:
- These variants are common — a large share of the population carries them.
- The findings are associations — relative shifts in likelihood across groups — not causation. A variant does not, by itself, cause any condition.
- Many people who carry these variants experience none of the associated patterns. Genes are one influence among many.
What we observe in clinical practice
In practice we consider AGT as one factor when looking at cardiovascular and blood-pressure health as a whole — alongside actual blood-pressure readings, lifestyle, and other markers. This is a clinical observation used case by case; it is not a diagnosis, and a genotype is not a reason to start or change any treatment on its own. Blood pressure is measured directly, and any management belongs with your doctor.
How to find your AGT result
Your existing 23andMe or AncestryDNA raw data file already contains your AGT markers — you do not need a new test. Uploading it produces a plain-language variant report showing your AGT result (and many others), which you can then review with your practitioner in the context of your whole health picture.
Order or view your report · Find a practitioner
Important note
This page is educational and is not a diagnosis or a treatment plan. These variants are common and shift relative likelihood, not certainty; many people who carry them experience none of the patterns described here. The clinical observations reflect what we have seen in practice and will not apply to everyone. Anything you wish to act on should be assessed individually with a qualified practitioner who can consider your full history, symptoms, and any relevant testing.
About the Author
Russell Browne (Dip. Adv. Nut.)
Specialist in Genetic Nutrition & Methylation Protocols
Russell Browne is a qualified practitioner of Advanced Nutrition, Advanced Herbalism, and Homeopathy, with a specialized clinical focus on genetic nutrition, methylation pathways, and detoxification. With years of dedicated clinical experience helping patients decode complex chronic health issues, Russell is also the author of How to Treat Your MTHFR Gene Mutations the Right Way – The Genetic Advantage and several works on genetic wellness. He is committed to bridging the gap between complex genetic data and practical, root-cause clinical care.
Read Russell’s Full Professional Profile & Clinical Credentials
View Published Genetic Health Literature & Books
